Bioymifi is a potent and selective small molecule agonist of DR5 that directly targets DR5, specifically binds the ECD of DR5 (Kd ~1.2 ??M), and induces the formation of DR5 aggregates and DR5 activation.
More Information Supplier PageBioymifi is a potent and selective small molecule agonist of DR5 that directly targets DR5, specifically binds the ECD of DR5 (Kd ~1.2 ??M), and induces the formation of DR5 aggregates and DR5 activation.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier PageLupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells.
More Information Supplier Page
